WWW.NYTIMES.COM
How Ozempic Maker Novo Nordisk Lost Its Shine
The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed its fortunes.
0 Commenti 0 condivisioni 2 Views 0 Anteprima